Fundamental Analysis
63 / 100ARubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | +142.8% | +37.1% | 2 / 3 | +33.7% | -10.52 pp | +0.82 pp | +0.9% | 0.17 | 20.26 | 93,3 | +33,7% | 1,7 | +142,8% | 20.26 | 18.89 | +7,3% |
| Pts | 12 | 8 | 8 | 12 | 0 | 8 | 0 | 12 | 8 | |||||||
Valuation annotation:Price: 2.200 (close price on 2026-10-19)EPS (TTM): 108,6
Financial charts
1.Revenue & growth
VND bn93,3Q2/26
1.Revenue & growth
VND bn93,3Q2/26
2.Profit & growth
VND bn1,61Q2/26
3.Profit mix (Penman)
VND bn8,60Q2/26
4.Margins & cost structure
%16.3%Q2/26
5.Returns & cash cycle
% · days1.6%Q2/26
6.Earnings quality & cash
VND bn-32,3Q2/26
7.Asset structure
VND bn810Q2/26
8.Funding & debt health
VND bn · times810Q2/26
9.Revenue backlog
VND bn0,09Q2/26
10.Valuation
times · %20,6×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %28Q2/26
Adjusted EPS growth, latest quarter
128%
Average adjusted EPS growth, 3 quarters
32.3%
Quarters at 25%+ growth
2/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26